A triple‐blind, placebo‐controlled, randomized clinical trial to evaluate the effect of curcumin‐containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID ‐19 patients-Reference-Cited by-同舟云学术

A triple‐blind, placebo‐controlled, randomized clinical trial to evaluate the effect of curcumin‐containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID ‐19 patients

Published:2021-09-19 Issue:11 Volume:35 Page:6417-6427
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Hassaniazad Mehdi¹,Eftekhar Ebrahim²,Inchehsablagh Behnaz Rahnama³⁴,Kamali Hossein³,Tousi Abdolali³,Jaafari Mahmoud Reza⁵⁶⁷,Rafat Milad³,Fathalipour Mohammad⁸,Nikoofal‐Sahlabadi Sara⁹,Gouklani Hamed¹,Alizade Hesam¹,Nikpoor Amin Reza¹⁰^ORCID

Affiliation:

1. Infectious and Tropical Diseases Research Center, Hormozgan Health Institute Hormozgan University of Medical Sciences Bandar Abbas Iran

2. Endocrinology and Metabolism Research Center Hormozgan University of Medical Sciences Bandar Abbas Iran

3. Student Research Committee, Faculty of Medicine Hormozgan University of Medical Sciences Bandar Abbas Iran

4. Department of Physiology, Faculty of Medicine Hormozgan University of Medical Sciences Bandar Abbas Iran

5. Nanotechnology Research Center, Pharmaceutical Technology Institute Mashhad University of Medical Sciences Mashhad Iran

6. Department of Pharmaceutical Nanotechnology, School of Pharmacy Mashhad University of Medical Sciences Mashhad Iran

7. Biotechnology Research Center, Pharmaceutical Technology Institute Mashhad University of Medical Sciences Mashhad Iran

8. Department of Pharmacology and Toxicology, Faculty of Pharmacy Hormozgan University of Medical Sciences Bandar Abbas Iran

9. Department of Pharmaceutics, Faculty of Pharmacy Hormozgan University of Medical Sciences Bandar Abbas Iran

10. Molecular Medicine Research Center, Hormozgan Health Institute Hormozgan University of Medical Sciences Bandar Abbas Iran

Funder

Hormozgan University of Medical Sciences

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7294

Reference42 articles.

1. The effects of curcumin supplementation on high‐sensitivity C‐reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial

2. Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral-induced Acute Respiratory Distress Syndrome

3. A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health

4. The role of neutrophil to lymphocyte count ratio in the differential diagnosis of pulmonary tuberculosis and bacterial community‐acquired pneumonia: A cross‐sectional study at Ayder and Mekelle Hospitals, Ethiopia;Berhane M.;Clinical Laboratory,2019

5. Curcumin Induces Glutathione Biosynthesis and Inhibits NF-κB Activation and Interleukin-8 Release in Alveolar Epithelial Cells: Mechanism of Free Radical Scavenging Activity

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals;International Journal of Molecular Sciences;2024-08-03

2. Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial;Journal of Health, Population and Nutrition;2024-06-24

3. Review from host and guest approach to new frontiers nutraceuticals in the era of COVID-19;Future Foods;2024-06

4. Optimizing the Antimicrobial Effects by using Natural Compounds in COVID-19 Management;Current Medicinal Chemistry;2024-05-23

5. Innovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations;Pharmaceutics;2024-05-09